Published in FEBS Lett on August 27, 2011
The membrane scaffold CD82 regulates cell adhesion by altering α4 integrin stability and molecular density. Mol Biol Cell (2014) 1.00
Bone marrow homing and engraftment of human hematopoietic stem and progenitor cells is mediated by a polarized membrane domain. Blood (2012) 0.93
The molecular effect of metastasis suppressors on Src signaling and tumorigenesis: new therapeutic targets. Oncotarget (2015) 0.87
Vpu is the main determinant for tetraspanin downregulation in HIV-1-infected cells. J Virol (2015) 0.84
Metastasis suppressors in breast cancers: mechanistic insights and clinical potential. J Mol Med (Berl) (2013) 0.84
Tetraspanin18 is a FoxD3-responsive antagonist of cranial neural crest epithelial-to-mesenchymal transition that maintains cadherin-6B protein. J Cell Sci (2013) 0.83
Metastasis suppressor tetraspanin CD82/KAI1 regulates ubiquitylation of epidermal growth factor receptor. J Biol Chem (2013) 0.82
Interaction between p68 RNA helicase and Ca2+-calmodulin promotes cell migration and metastasis. Nat Commun (2013) 0.82
ALY as a potential contributor to metastasis in human oral squamous cell carcinoma. J Cancer Res Clin Oncol (2012) 0.80
The role of TREX in gene expression and disease. Biochem J (2016) 0.79
Expression characteristics of KAI1 and vascular endothelial growth factor and their diagnostic value for hepatocellular carcinoma. Gut Liver (2014) 0.77
Identification of the tetraspanin CD82 as a new barrier to xenotransplantation. J Immunol (2013) 0.77
CD82 suppresses CD44 alternative splicing-dependent melanoma metastasis by mediating U2AF2 ubiquitination and degradation. Oncogene (2016) 0.76
Identification of biological markers of liver X receptor (LXR) activation at the cell surface of human monocytes. PLoS One (2012) 0.76
Expression of the Metastasis Suppressor KAI1 in Uveal Melanoma. J Ophthalmol (2013) 0.76
Loss of tumor suppressors KAI1 and p27 identifies a unique subgroup of primary melanoma patients with poor prognosis. Oncotarget (2015) 0.76
TIMP-1 and CD82, a promising combined evaluation marker for PDAC. Oncotarget (2016) 0.75
Molecular cloning, expression pattern, and phylogenetic analysis of a tetraspanin CD82-like molecule in lamprey Lampetra japonica. Dev Genes Evol (2016) 0.75
ΔNp63α promotes adhesion of metastatic prostate cancer cells to the bone through regulation of CD82. Oncogene (2017) 0.75
Exosomes: composition, biogenesis and function. Nat Rev Immunol (2002) 13.99
Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J Biol Chem (1998) 5.79
SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature (2008) 4.27
CAS/Crk coupling serves as a "molecular switch" for induction of cell migration. J Cell Biol (1998) 4.22
KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science (1995) 3.97
The tumor autocrine motility factor receptor, gp78, is a ubiquitin protein ligase implicated in degradation from the endoplasmic reticulum. Proc Natl Acad Sci U S A (2001) 3.39
Exosome release of β-catenin: a novel mechanism that antagonizes Wnt signaling. J Cell Biol (2010) 2.85
Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression. Nat Med (2006) 2.57
Transcriptional regulation of a metastasis suppressor gene by Tip60 and beta-catenin complexes. Nature (2005) 2.43
The activity of a human endoplasmic reticulum-associated degradation E3, gp78, requires its Cue domain, RING finger, and an E2-binding site. Proc Natl Acad Sci U S A (2006) 2.41
Tetraspanins as regulators of protein trafficking. Traffic (2006) 1.98
CD81 extracellular domain 3D structure: insight into the tetraspanin superfamily structural motifs. EMBO J (2001) 1.90
The ubiquitin ligase gp78 promotes sarcoma metastasis by targeting KAI1 for degradation. Nat Med (2007) 1.81
The Unfolded Protein Response, Degradation from Endoplasmic Reticulum and Cancer. Genes Cancer (2010) 1.55
Roles of sumoylation of a reptin chromatin-remodelling complex in cancer metastasis. Nat Cell Biol (2006) 1.52
Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss. Cancer Res (1996) 1.50
Ganglioside GM2-tetraspanin CD82 complex inhibits met and its cross-talk with integrins, providing a basis for control of cell motility through glycosynapse. J Biol Chem (2007) 1.40
Tetraspanin KAI1/CD82 suppresses invasion by inhibiting integrin-dependent crosstalk with c-Met receptor and Src kinases. Oncogene (2006) 1.37
The tumor metastasis suppressor gene Drg-1 down-regulates the expression of activating transcription factor 3 in prostate cancer. Cancer Res (2006) 1.35
The Duffy antigen/receptor for chemokines (DARC) regulates prostate tumor growth. FASEB J (2006) 1.33
Attenuation of EGF receptor signaling by a metastasis suppressor, the tetraspanin CD82/KAI-1. Curr Biol (2000) 1.33
Assembly of urothelial plaques: tetraspanin function in membrane protein trafficking. Mol Biol Cell (2005) 1.27
Motility inhibition and apoptosis are induced by metastasis-suppressing gene product CD82 and its analogue CD9, with concurrent glycosylation. Cancer Res (1999) 1.26
Overexpression of KAI1 suppresses in vitro invasiveness and in vivo metastasis in breast cancer cells. Cancer Res (2001) 1.23
The palmitoylation of metastasis suppressor KAI1/CD82 is important for its motility- and invasiveness-inhibitory activity. Cancer Res (2004) 1.22
The autocrine motility factor receptor gene encodes a novel type of seven transmembrane protein. FEBS Lett (1999) 1.21
Complete predicted three-dimensional structure of the facilitator transmembrane protein and hepatitis C virus receptor CD81: conserved and variable structural domains in the tetraspanin superfamily. Biophys J (2006) 1.18
The expression of the KAI1 gene, a tumor metastasis suppressor, is directly activated by p53. Proc Natl Acad Sci U S A (1998) 1.16
Glutathione export during apoptosis requires functional multidrug resistance-associated proteins. J Biol Chem (2007) 1.15
Purification of human tumor cell autocrine motility factor and molecular cloning of its receptor. J Biol Chem (1991) 1.12
CD82 metastasis suppressor gene: a potential target for new therapeutics? Trends Mol Med (2005) 1.11
EWI2/PGRL associates with the metastasis suppressor KAI1/CD82 and inhibits the migration of prostate cancer cells. Cancer Res (2003) 1.08
KAI1 gene is engaged in NDRG1 gene-mediated metastasis suppression through the ATF3-NFkappaB complex in human prostate cancer. J Biol Chem (2011) 1.07
Suppression of epidermal growth factor receptor signaling by protein kinase C-alpha activation requires CD82, caveolin-1, and ganglioside. Cancer Res (2007) 1.06
Vangl1 protein acts as a downstream effector of intestinal trefoil factor (ITF)/TFF3 signaling and regulates wound healing of intestinal epithelium. J Biol Chem (2006) 1.06
KAI1 COOH-terminal interacting tetraspanin (KITENIN), a member of the tetraspanin family, interacts with KAI1, a tumor metastasis suppressor, and enhances metastasis of cancer. Cancer Res (2004) 1.05
Tetraspanin CD82 regulates compartmentalisation and ligand-induced dimerization of EGFR. J Cell Sci (2003) 1.04
Reduced invasive and metastatic potentials of KAI1-transfected melanoma cells. Jpn J Cancer Res (1998) 1.04
Regulation of c-Met signaling by the tetraspanin KAI-1/CD82 affects cancer cell migration. Int J Cancer (2007) 1.02
The involvement of hypoxia-inducible transcription factor-1-dependent pathway in nickel carcinogenesis. Cancer Res (2003) 1.02
Suppression of invasive properties of colon cancer cells by a metastasis suppressor KAI1 gene. Oncogene (1998) 1.01
Glycosylation effect on membrane domain (GEM) involved in cell adhesion and motility: a preliminary note on functional alpha3, alpha5-CD82 glycosylation complex in ldlD 14 cells. Biochem Biophys Res Commun (2000) 1.00
Mutation and expression of the metastasis suppressor gene KAI1 in esophageal squamous cell carcinoma. Cancer (2000) 0.99
Further characterization of CD82/IA4 antigen (type III surface protein): an activation/differentiation marker of mononuclear cells. Cell Immunol (1994) 0.99
KAI1 promoter activity is dependent on p53, junB and AP2: evidence for a possible mechanism underlying loss of KAI1 expression in cancer cells. Oncogene (2005) 0.99
A novel function of CD82/KAI-1 on E-cadherin-mediated homophilic cellular adhesion of cancer cells. Cancer Lett (2008) 0.98
The metastasis suppressor gene C33/CD82/KAI1 induces apoptosis through reactive oxygen intermediates. FASEB J (2003) 0.98
Tetraspanin CD82 attenuates cellular morphogenesis through down-regulating integrin alpha6-mediated cell adhesion. J Biol Chem (2004) 0.98
Regulation of urokinase receptor proteolytic function by the tetraspanin CD82. J Biol Chem (2005) 0.98
Requirement of the p130CAS-Crk coupling for metastasis suppressor KAI1/CD82-mediated inhibition of cell migration. J Biol Chem (2003) 0.97
Metastasis-suppressor KAI1/CD82 induces homotypic aggregation of human prostate cancer cells through Src-dependent pathway. Exp Mol Med (2003) 0.97
Transmembrane interactions are needed for KAI1/CD82-mediated suppression of cancer invasion and metastasis. Am J Pathol (2008) 0.97
Methylation of a CpG island within the promoter region of the KAI1 metastasis suppressor gene is not responsible for down-regulation of KAI1 expression in invasive cancers or cancer cell lines. Cancer Lett (2000) 0.96
CD82, member of the tetra-span-transmembrane protein family, is a costimulatory protein for T cell activation. J Immunol (1995) 0.94
CD82 gene suppression in endometrial stromal cells leads to increase of the cell invasiveness in the endometriotic milieu. J Mol Endocrinol (2011) 0.92
Quality control of transmembrane domain assembly in the tetraspanin CD82. EMBO J (2001) 0.92
KAI1/CD82 suppresses tumor invasion by MMP9 inactivation via TIMP1 up-regulation in the H1299 human lung carcinoma cell line. Biochem Biophys Res Commun (2006) 0.91
Expression of the metastasis suppressor KAI1 in decidual cells at the human maternal-fetal interface: Regulation and functional implications. Am J Pathol (2007) 0.91
Effect of KAI1/CD82 on the beta1 integrin maturation in highly migratory carcinoma cells. Biochem Biophys Res Commun (2007) 0.91
Frequent down-regulation and lack of mutation of the KAI1 metastasis suppressor gene in epithelial ovarian carcinoma. Gynecol Oncol (2000) 0.91
The 4F9 antigen is a member of the tetra spans transmembrane protein family and functions as an accessory molecule in T cell activation and adhesion. Cell Immunol (1993) 0.89
KAI1 is a potential target for anti-metastasis in pancreatic cancer cells. World J Gastroenterol (2008) 0.88
Overexpression of tetraspanins affects multiple myeloma cell survival and invasive potential. FASEB J (2007) 0.87
Down-regulation of KAI1 messenger RNA expression is not associated with loss of heterozygosity of the KAI1 gene region in lung adenocarcinoma. Jpn J Cancer Res (1999) 0.87
Identification of regulatory regions within the KAI1 promoter: a role for binding of AP1, AP2 and p53. Gene (2003) 0.87
KAI1 gene suppresses invasion and metastasis of hepatocellular carcinoma MHCC97-H cells in vitro and in animal models. Liver Int (2007) 0.86
Relationship between expression of KAI1 metastasis suppressor gene, mRNA levels and p53 in human bladder and prostate cancer cell lines. Urol Oncol (2002) 0.86
Activation of the tumor metastasis suppressor gene, KAI1, by etoposide is mediated by p53 and c-Jun genes. Biochem Biophys Res Commun (2000) 0.86
A role for KAI1 in promotion of cell proliferation and mammary gland hyperplasia by the gp78 ubiquitin ligase. J Biol Chem (2010) 0.85
Suppression of telomerase, reexpression of KAI1, and abrogation of tumorigenicity by nerve growth factor in prostate cancer cell lines. Clin Cancer Res (1999) 0.85
Tetraspanin-induced death of myeloma cell lines is autophagic and involves increased UPR signalling. Br J Cancer (2009) 0.84
Duffy antigen/receptor for chemokines (DARC) attenuates angiogenesis by causing senescence in endothelial cells. Angiogenesis (2007) 0.84
Identification of the KAI1 metastasis suppressor gene as a hypoxia target gene. Biochem Biophys Res Commun (2010) 0.84
The Duffy Antigen/Receptor for Chemokines (DARC) and prostate-cancer risk among Jamaican men. J Immigr Minor Health (2011) 0.83
Role of tumor metastasis suppressor gene KAI1 in digestive tract carcinomas and cancer cells. Cell Tissue Res (2003) 0.82
CD82, tetra-span-transmembrane protein, is a regulated transducing molecule on U937 monocytic cell line. J Leukoc Biol (1995) 0.81
Downregulation of KAI1 mRNA in localised prostate cancer and its bony metastases does not correlate with p53 overexpression. Prostate Cancer Prostatic Dis (2003) 0.81
Glycosylation of tetraspanin Tspan-1 at four distinct sites promotes its transition through the endoplasmic reticulum. Protein Pept Lett (2009) 0.81
Induction of KAI-1 expression in metastatic cancer cells by phorbol esters. Cancer Lett (2000) 0.80
Absence of p53-dependent induction of the metastatic suppressor KAI1 gene after DNA damage. Oncogene (2000) 0.79
Overexpression of KAI1 induces autophagy and increases MiaPaCa-2 cell survival through the phosphorylation of extracellular signal-regulated kinases. Biochem Biophys Res Commun (2010) 0.78
Defining regulatory elements in the human KAI1 (CD 82) metastasis suppressor gene. Prostate (2003) 0.78
Mind bomb is a ubiquitin ligase that is essential for efficient activation of Notch signaling by Delta. Dev Cell (2003) 4.30
SINAT5 promotes ubiquitin-related degradation of NAC1 to attenuate auxin signals. Nature (2002) 2.94
Structural basis for ubiquitin recognition and autoubiquitination by Rabex-5. Nat Struct Mol Biol (2006) 2.85
Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeutics. Cancer Res (2007) 2.60
The activity of a human endoplasmic reticulum-associated degradation E3, gp78, requires its Cue domain, RING finger, and an E2-binding site. Proc Natl Acad Sci U S A (2006) 2.41
A conserved catalytic residue in the ubiquitin-conjugating enzyme family. EMBO J (2003) 2.37
Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells. Cancer Cell (2005) 2.17
Ubiquitin ligases, critical mediators of endoplasmic reticulum-associated degradation. Semin Cell Dev Biol (2007) 2.13
BTBD1 and BTBD2 colocalize to cytoplasmic bodies with the RBCC/tripartite motif protein, TRIM5delta. Exp Cell Res (2003) 2.06
RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis. Nat Rev Cancer (2011) 2.06
Nedd4 mediates agonist-dependent ubiquitination, lysosomal targeting, and degradation of the beta2-adrenergic receptor. J Biol Chem (2008) 2.00
HECT and RING finger families of E3 ubiquitin ligases at a glance. J Cell Sci (2012) 1.95
Allosteric activation of E2-RING finger-mediated ubiquitylation by a structurally defined specific E2-binding region of gp78. Mol Cell (2009) 1.83
The ubiquitin ligase gp78 promotes sarcoma metastasis by targeting KAI1 for degradation. Nat Med (2007) 1.81
WW domain HECT E3s target Cbl RING finger E3s for proteasomal degradation. J Biol Chem (2003) 1.79
Differences in the tumor microenvironment between African-American and European-American breast cancer patients. PLoS One (2009) 1.72
The Rab5 guanine nucleotide exchange factor Rabex-5 binds ubiquitin (Ub) and functions as a Ub ligase through an atypical Ub-interacting motif and a zinc finger domain. J Biol Chem (2006) 1.68
CAIR-1/BAG-3 abrogates heat shock protein-70 chaperone complex-mediated protein degradation: accumulation of poly-ubiquitinated Hsp90 client proteins. J Biol Chem (2003) 1.67
Ubiquitin-proteasome-dependent degradation of a mitofusin, a critical regulator of mitochondrial fusion. Mol Biol Cell (2008) 1.66
RING-type E3 ligases: master manipulators of E2 ubiquitin-conjugating enzymes and ubiquitination. Biochim Biophys Acta (2013) 1.64
The Unfolded Protein Response, Degradation from Endoplasmic Reticulum and Cancer. Genes Cancer (2010) 1.55
Malfolded protein structure and proteostasis in lung diseases. Am J Respir Crit Care Med (2014) 1.47
Stress-induced phosphorylation and proteasomal degradation of mitofusin 2 facilitates mitochondrial fragmentation and apoptosis. Mol Cell (2012) 1.46
RING finger ubiquitin protein ligases: implications for tumorigenesis, metastasis and for molecular targets in cancer. Semin Cancer Biol (2003) 1.42
Regulating the p53 system through ubiquitination. Oncogene (2004) 1.39
Overexpression of the tumor autocrine motility factor receptor Gp78, a ubiquitin protein ligase, results in increased ubiquitinylation and decreased secretion of apolipoprotein B100 in HepG2 cells. J Biol Chem (2003) 1.37
Ubiquitin charging of human class III ubiquitin-conjugating enzymes triggers their nuclear import. J Cell Biol (2004) 1.33
Serine residues in the cytosolic tail of the T-cell antigen receptor alpha-chain mediate ubiquitination and endoplasmic reticulum-associated degradation of the unassembled protein. J Biol Chem (2010) 1.18
E6AP mediates regulated proteasomal degradation of the nuclear receptor coactivator amplified in breast cancer 1 in immortalized cells. Cancer Res (2006) 1.08
A mutation associated with CMT2A neuropathy causes defects in Fzo1 GTP hydrolysis, ubiquitylation, and protein turnover. Mol Biol Cell (2009) 1.08
Inositol 1,4,5-trisphosphate receptor ubiquitination is mediated by mammalian Ubc7, a component of the endoplasmic reticulum-associated degradation pathway, and is inhibited by chelation of intracellular Zn2+. J Biol Chem (2003) 1.06
Identification of developmentally expressed proteins that functionally interact with Nedd4 ubiquitin ligase. J Biol Chem (2001) 1.06
Allosteric regulation of E2:E3 interactions promote a processive ubiquitination machine. EMBO J (2013) 1.05
Targeting of gp78 for ubiquitin-mediated proteasomal degradation by Hrd1: cross-talk between E3s in the endoplasmic reticulum. Biochem Biophys Res Commun (2009) 1.03
A Ubc7p-binding domain in Cue1p activates ER-associated protein degradation. J Cell Sci (2009) 1.01
Sequential requirements for the GTPase domain of the mitofusin Fzo1 and the ubiquitin ligase SCFMdm30 in mitochondrial outer membrane fusion. J Cell Sci (2011) 0.97
Multiple roles of Rbx1 in the VBC-Cul2 ubiquitin ligase complex. Genes Cells (2005) 0.96
Expression, purification, and properties of the Ubc4/5 family of E2 enzymes. Methods Enzymol (2005) 0.96
A structurally unique E2-binding domain activates ubiquitination by the ERAD E2, Ubc7p, through multiple mechanisms. Mol Cell (2013) 0.95
Differential regulation of HMG-CoA reductase and Insig-1 by enzymes of the ubiquitin-proteasome system. Mol Biol Cell (2012) 0.95
Targeting botulinum neurotoxin persistence by the ubiquitin-proteasome system. Proc Natl Acad Sci U S A (2010) 0.94
EGF receptor-independent action of TGF-alpha protects Naked2 from AO7-mediated ubiquitylation and proteasomal degradation. Proc Natl Acad Sci U S A (2008) 0.93
Ubiquitylation in ERAD: reversing to go forward? PLoS Biol (2011) 0.92
Targeting tumor cells expressing p53 with a water-soluble inhibitor of Hdm2. Mol Cancer Ther (2008) 0.92
Identification of inhibitors for MDM2 ubiquitin ligase activity from natural product extracts by a novel high-throughput electrochemiluminescent screen. J Biomol Screen (2008) 0.89
Compact Parkin only: insights into the structure of an autoinhibited ubiquitin ligase. EMBO J (2013) 0.86
Expression and evaluation of RING finger proteins. Methods Enzymol (2005) 0.85
Studies of the ubiquitin proteasome system. Curr Protoc Cell Biol (2006) 0.84
Promiscuous interactions of gp78 E3 ligase CUE domain with polyubiquitin chains. Structure (2012) 0.84
Working on a chain: E3s ganging up for ubiquitylation. Nat Cell Biol (2010) 0.82
Discovery of new pyridoacridine alkaloids from Lissoclinum cf. badium that inhibit the ubiquitin ligase activity of Hdm2 and stabilize p53. Bioorg Med Chem (2008) 0.82
A ubiquitin-binding rhomboid protease aimed at ERADication. Dev Cell (2012) 0.76
Cullin RING ligases: glommed by glomulin. Mol Cell (2012) 0.75
Ubiquitin and drug discovery: challenges and opportunities. Cell Biochem Biophys (2013) 0.75